Skip to main content
. Author manuscript; available in PMC: 2009 Oct 2.
Published in final edited form as: Pediatr Infect Dis J. 2009 Feb;28(2):159–161. doi: 10.1097/INF.0b013e3181861d8b

TABLE 1.

Median (Range) Lopinavir, Ritonavir, and Efavirenz Pharmacokinetics

Cmax (mg/L) Tmax (hr) t1/2 (hr) Cmin (mg/L) AUCτ (mg × hr/L) V (L) CL (L/h)
LPV 12.0 (1.5–36.6) 3.0 (2.0–11.8) 9.3 (4.6–19.1) 6.3 (0.7–25.1) 100.2 (13.4–318.5) 26.8 (8.7–177.9) 2.4 (0.57–20.25)
RTV 1.0 (0.04–3.7) 3.0 (1.0–8.1) 4.5 (3.1–8.2) 0.3 (0.01–1.2) 6.6 (0.3–28.9) 69.1 (16.2–1708) 11.8 (2.0–264.8)
EFV 3.57 (1.4–7.6) 3.0 (2.0–11.9) 9.94 (4.9–27.8) 0.77 (0.2–2.5) 40.87 (13.7–86.2) 104.76 (64.0–343.0) 8.5 (2.3–22.9)

AUCτ was AUC12 for LPV and AUC24 for EFV.

Cmin was C12 h for LPV and estimated C24 h (EstC24 h) for EFV.